Hi Bob
The Dowsett Ramsay paper published in 1990 is an interesting paper.
I see you have also referred to little bits of the paper that you have found personally interesting, which I agree with you they are. But context is important both with respect to how those little bits of information sit within the overall document, its focus and intent - as well as a more extensive body of work.
The opening paragraph of that study makes it clear, that purpose of this study was two fold:
(a) one to demonstrate the association bewteeen ME and enteroviral infection and
(b) two that unique clinical and epidemiological patterns associated with enteroviral infection distinguish ME from PVF states.
The study co hort was selected from 6.000 of Dr Ramasays patients he had seen over a period of 12 years from 1975-87. 77% came from general practice and 23% were referred from hospital specialists.
From this large group, 402 were chosen for the purposes of this further study.
I refer to my earlier post to Bob discussing the difficulty detection enteroviruses outside of an epidemic setting (due to serology limitations and the flux of time). I suggest this was one reason for the need to identify a co hort that was likely to return a positive enteroviral finding for the purposes of the study.
Hence, a specific criteria was designed to select such patients - but again, it was for the purposes of this study. I view this in the same context as what the WPI did when they went looking for XMRV. They selected patients that were presenting with certain clinical features, which suggested to them that this would give them the best chances of finding XMRV in that group.
The criteria they used for the purposes of selecting a study co hort:
*illness initiation by respiratory and or gastro intestinal infection (common trait of enteroviral infection)
*neurological (CNS) disability and
*cardiac disability or
*endocrine disability
Signs of ME selected for
*neurological CNS disturbance - especially cognitive, autonomic nervous system dysfunction and sensory dysfunction
*cardiac and other system involvement (of a varible nature)
*general or local muscle fatigue following minimal exertion with prolonged recovery time.
Results.
One of the first points made is that results show acute or sudden onset in 81% of patients. As previously pointed out, a key feature of historical enteroviral ME.
This is not a feature required in any CFS definition.
The results then go on to discuss clinical characteristics.
The first point discussed is the duration and severity of the illness of the 402 subjects.
At the time of the study, patients reported being ill for the following durations.
9% had been ill for less than 12 months
32% between 1-2 years
47% between 3-10 years
8% 11-20 years
4% 21-60 years
Over this spread, illness was reported to be
improving in 31
fluctuating in 21
stead disability in 25
no remission or worse in 24
Consequently, the table of symptoms table and the symptoms in it (ie muscle fatigue) you posted, must be seen in light of this data.
In the commentary they also suggest that symptoms associated with enteroviral infection also vary due to age, susceptibility of the host, viral strain and virulence.
I would also suggest to you Bob, that 100% muscle fatigue (a very specific type) found in the co hort, although high, is not surprising because it was specifically selected for amongst the co hort in the studies design.
Further, the emphasis on this as a selection criteria, was I beleive, to demonstrate this feature as one of many in ME, that can be easily used to distinguish it from PVF states. That was, after all, one of the intentions of the study - to demonstrate how you could distinguish enteroviral ME from PVFS. It was not and should but be otherwise used to elevate this symptom as the key criteria to be selected for in ME, because it is not. It is not consistent with the general body of ME literature. It is a feature though.
Here's a description of the clinical criteria that they used for 'ME' in this paper. Fatigue does seem to be a prominent factor in the illness.........
Therefore, whilst it might appear from reading the isolated paragraph Bob referred to suggest that fatigue (and I might add, a specific kind of fatigue) is a prominent factor in the illness, this is IMO a mistaken view, that cannot be supported either on the basis of the study itself or within the broader body of literature on historic ME.
Bob, no one has suggested that enteroviral infection must be found 100% of the time. I alluded to the problem with this in the post I made to you regarding epidemics and sporadic cases and the limitations of serology/stool tests which made (and still do so) hard to return a positive finding. Though the literature on epidemics is what has given rise to this very strong enteroviral association. Evidence of enteroviral damage to the CNS has been found in the historic ME literature. This is why emphasis is placed on SPECT, PET, MRI, QEEG, etc is made - and when taken with other evidence ie: acute onset illness etc and other signs and tests - show that this is consistent with ME entroviral infection (even though enteroviral detection might be illusive because of general serology and stool based tests.
The findings of this study with respect to evidence of Coxsackie enteroviral infection - were impressive -given the limitations for detecting enetroviral infections (on this point, Dr John Chia would agree I am sure. You might like to read the interview Cort posted between himself and Dr Chia who, in his own studies, had to run multiple tests over a long period - in order to get a positive test result....which is why he developed stomach tissue biopsy and analysis). On this point, you might also like to note that 91% of the co hort had been ill for more than 12 months. Findings are also difficult to pin point because, as stated by the authors of the study - a variation in the viralence of the strain in individuals, the age and susceptibility of the individual. On that point, I note that 50% of the co hort were improving and or their symptoms fluctuating. This would also explain and be consistent with the results of the stuy with regard to evidence of enteroviral infection in this co hort.
The study however, reminds the scientific community of what they know: that enteroviral infection is common. Most doctors will agree and believe it is trivial. It is in 95% of cases, but for 5% (as historic Polio and Non paralytic polio cases showed) it can be severe and life threatening illness. The study reports that enteroviral infection is common and that this was the rationale for introducing polio vaccines. The study also makes mention of the difficulties associated with testing.
In all, this study outcome produced a very good result.
They are more impressive when you understand that the co hort had been suffering from ME many months and sometimes many years away from the incute onset enteroviral infection.